ImmunityBio, Inc.IBRXNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank75
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-5.90
↑ 55% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-13.16
Historical baseline
PeriodValueYoY Change
2025-5.90-31.5%
2024-4.48+30.2%
2023-6.43-31.7%
2022-4.88+36.5%
2021-7.68+73.9%
2020-29.46-217.2%
2019-9.29-88.4%
2018-4.93+71.0%
2017-16.98+59.2%
2016-41.62-